We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$237M
AUM Growth
+$17.9M
Cap. Flow
+$325K
Cap. Flow %
0.14%
Top 10 Hldgs %
29.98%
Holding
77
New
4
Increased
27
Reduced
36
Closed
4

Top Buys

Rank Stock Value
1
NEU icon
NewMarket
NEU
+$588K
2
AMGN icon
Amgen
AMGN
+$557K
3
TJX icon
TJX Companies
TJX
+$494K
4
CNI icon
Canadian National Railway
CNI
+$386K
5
CLB icon
Core Laboratories
CLB
+$356K

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$790K
2
PII icon
Polaris
PII
+$626K
3
GILD icon
Gilead Sciences
GILD
+$563K
4
PG icon
Procter & Gamble
PG
+$457K
5
CLX icon
Clorox
CLX
+$299K

Sector Composition

Rank Sector Weight
1 Technology 18.18%
2 Consumer Discretionary 17.52%
3 Healthcare 17.36%
4 Industrials 13.36%
5 Consumer Staples 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLGN icon
26
Silgan Holdings
SLGN
$4.99B
$4.45M 1.88%
189,562
+5,990
+3% +$144K
ALTR
27
DELISTED
Altera Corp
ALTR
$4.43M 1.87%
119,290
-685
-0.6% -$24.6K
TJX icon
28
TJX Companies
TJX
$171B
$4.32M 1.82%
153,214
+18,550
+14% +$494K
CBRL icon
29
Cracker Barrel
CBRL
$1.2B
$4.07M 1.71%
39,422
+378
+1% +$37.9K
AMGN icon
30
Amgen
AMGN
$198B
$3.74M 1.58%
33,418
+5,139
+18% +$557K
K
31
DELISTED
Kellanova
K
$3.7M 1.56%
67,183
+21
+0% +$1.25K
CPRT icon
32
Copart
CPRT
$25.6B
$3.63M 1.53%
914,896
-28,400
-3% -$116K
TPR icon
33
Tapestry
TPR
$28.6B
$3.37M 1.42%
61,892
+1,152
+2% +$63.4K
DLTR icon
34
Dollar Tree
DLTR
$24.2B
$3.28M 1.38%
57,352
+315
+0.6% +$17K
ABBV icon
35
AbbVie
ABBV
$450B
$3.13M 1.32%
70,098
+770
+1% +$34.1K
COL
36
DELISTED
Rockwell Collins
COL
$3.08M 1.3%
45,442
-847
-2% -$59.9K
EXPD icon
37
Expeditors International
EXPD
$23.9B
$2.99M 1.26%
67,879
-2,500
-4% -$104K
PDCO
38
DELISTED
Patterson Companies, Inc.
PDCO
$2.78M 1.17%
69,254
-100
-0.1% -$4.05K
NVO
39
Novo Nordisk
NVO
$223B
$2.69M 1.13%
158,740
+6,320
+4% +$106K
DHR icon
40
Danaher
DHR
$144B
$2.61M 1.1%
56,088
-261
-0.5% -$11.8K
XOM icon
41
ExxonMobil
XOM
$611B
$2.56M 1.08%
29,803
-175
-0.6% -$15.8K
ABT icon
42
Abbott
ABT
$175B
$2.54M 1.07%
76,503
+425
+0.6% +$14.9K
IBM icon
43
IBM
IBM
$200B
$2.48M 1.05%
14,022
-78
-0.6% -$14.2K
CSCO icon
44
Cisco
CSCO
$441B
$2.33M 0.98%
99,694
-2,560
-3% -$63.6K
KMB icon
45
Kimberly-Clark
KMB
$36B
$2.15M 0.9%
23,760
-907
-4% -$84K
LH icon
46
Labcorp
LH
$23.2B
$2.09M 0.88%
24,543
+349
+1% +$29.4K
MTD icon
47
Mettler-Toledo International
MTD
$26.5B
$1.82M 0.77%
7,585
-305
-4% -$68.8K
CNI icon
48
Canadian National Railway
CNI
$78.3B
$1.75M 0.74%
34,502
+7,820
+29% +$386K
LLY icon
49
Eli Lilly
LLY
$1.05T
$1.64M 0.69%
32,609
-300
-0.9% -$15.7K
TECH icon
50
Bio-Techne
TECH
$11.2B
$1.6M 0.67%
79,920
-800
-1% -$15.2K
1
2
3 4

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
FCM
Fourpath Capital Management Oklahoma City, Oklahoma $697M AUM 29.98% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JLB & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, JLB & Associates held 77 positions worth $237M, up 8.2% from $219M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

JLB & Associates's Q3 2013 filing shows 4 new, 27 increased, 36 reduced and 4 closed positions. Its largest new stake was Core Laboratories: 2,295 shares worth $388K. The largest sale was Lockheed Martin, an estimated $790K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • JLB & Associates's largest Q3 2013 buy was Core Laboratories: 2,295 shares worth $388K.
  • JLB & Associates added most to NewMarket in Q3 2013, an estimated $588K increase.
  • JLB & Associates's biggest Q3 2013 reduction was Polaris, cutting an estimated $626K.
  • JLB & Associates fully exited Lockheed Martin in Q3 2013, selling an estimated $790K.
  • JLB & Associates's ten largest holdings make up 30% of its $237M portfolio in Q3 2013.
  • JLB & Associates opened 4 new positions and closed 4 in Q3 2013.
  • JLB & Associates's portfolio value rose 8.2% quarter-over-quarter to $237M.

Based on JLB & Associates's 13F filing for Q3 2013, filed 7 Oct 2013.